ArticleDigital health
Reliability and readability of adenoid hypertrophy information generated by five publicly accessible LLM chatbots: A default-setting snapshot study.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study evaluated the performance of five major large language model (LLM) chatbots in generating patient-oriented information on adenoid hypertrophy, focusing on content reliability and readability. Methods: Sixty-three frequently asked questions (FAQs) on adenoid hypertrophy were collected, covering seven domains including etiology, symptoms, and treatment. From October 1, 2025, to January 10, 2026, questions were submitted in English to five LLMs via their official web interfaces. Reliability was assessed using DISCERN, EQIP, JAMA benchmarks, and the Global Quality Scale (GQS). Readability was measured by six standard indices (ARI, CLI, FKGL, GFI, SMOG, FRES). Three otorhinolaryngology clinicians blindly scored all responses. Results: Significant differences in reliability were found among models ( Conclusion: Current LLMs show a notable imbalance between reliability and readability in generating adenoid hypertrophy information, with none excelling in both. In this default-setting, product-level snapshot, Perplexity showed higher information-quality scores, whereas Gemini generated comparatively easier-to-read responses. These findings should not be interpreted as a controlled benchmark of underlying base models. Limitations include potential prompt sensitivity, single-response sampling, and the snapshot nature of the assessment given rapid model updates. Future improvements should focus on source transparency, text simplification, and condition-specific evaluation to enhance AI-assisted health communication for pediatric care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.